Public & Press

EU related publications

EANM’s contributions to the European Commission’s Consultation on Revision of the EU general pharmaceuticals legislation

As part of the EU pharmaceuticals strategy, and drawing lessons from the COVID-19 pandemic, the European Commission plans to evaluate and revise the EU’s general legislation on medicines for human use to ensure a future-proof and crisis-resistant medicines regulatory system.
Legal proposals to review Directive 2001/83/EC and Regulation EC/726/2004 are to be expected for the end of 2022.

The EANM’s main points of concern have been summarised in a briefing paper.

Co-ordinated Approach to the Development and Supply of Radionuclides in the EU

European Commission, October 2021

 

Study on sustainable and resilient supply of medical radioisotopes in the EU – Therapeutic radionuclides (SMER2)

European Commission, Joint Research Center, June 2021

 

Horizon Europe  Health Work Programme 2021-2022

European Commission, June 2021

 

Horizon Europe Strategic Plan 2021-2024

European Commission, March 2021

 

EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy

EJNMMI – European Journal of Nuclear Medicine and Molecular Imaging, October 2020

 

Coalition Statement on Reducing bureaucracy in clinical trials  

Joint statement by medical societies and patient advocates, September 2020

 

NMEu Communication to the European Observatory for the supply of radioisotopes for medical use

Nuclear Medicine Europe (NMEu), The Industry Association, December 2019

 

EURATOM Supply Agency Annual Report 2018

Euratom Supply Agency (ESA), June 2019

 

“Securing the European Supply of 19.75% enriched Uranium Fuel. A revised assessment.”

Euratom Supply Agency (ESA), May 2019

 

“European Study on Medical, Industrial and Research Applications of Nuclear and Radiation Technology – Final Report” (SAMIRA)

Directorate-General for Energy (European Commission), Technopolis Group, February 2019

 

This website uses cookies. Learn more